NCT01351103 2025-06-13A Study of LGK974 in Patients With Malignancies Dependent on Wnt LigandsNovartisPhase 1 Completed185 enrolled
NCT03499899 2023-01-30A Study of Efficacy and Safety of LAG525 in Combination With Spartalizumab, or With Spartalizumab and Carboplatin, or With Carboplatin, in Patients With Advanced Triple-negative Breast CancerNovartisPhase 2 Completed88 enrolled 35 charts
NCT02890069 2023-01-11A Study of PDR001 in Combination With LCL161, Everolimus or PanobinostatNovartisPhase 1 Completed298 enrolled
NCT02404441 2022-08-03Phase I/II Study of PDR001 in Patients With Advanced MalignanciesNovartisPhase 1/2 Completed319 enrolled 41 charts
NCT02900664 2022-03-29A Study of PDR001 in Combination With CJM112, EGF816, IlarisĀ® (Canakinumab) or MekinistĀ® (Trametinib)NovartisPhase 1 Completed283 enrolled
NCT02947165 2022-01-31Phase I/Ib Study of NIS793 in Combination With PDR001 in Patients With Advanced Malignancies.NovartisPhase 1 Completed120 enrolled
NCT02807844 2021-08-11Phase Ib/II Study of MCS110 in Combination With PDR001 in Patients With Advanced MalignanciesNovartisPhase 1/2 Completed141 enrolled 58 charts